Summary
Updated Aug 31, 2026
Charles M. Baum files SEC Form 4 reports at Acrivon Therapeutics, Inc. (ACRV). 3 SEC Form 4 filings on record, most recently on 22 June 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Charles M. Baum has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Charles M. Baum files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ORBIMED ADVISORS LLC - $2.42M of PMVP open-market activity in the last 12 months
- Peter Blume-Jensen - $117K of ACRV open-market activity in the last 12 months
- Eric Devroe - $18K of ACRV open-market activity in the last 12 months
- Adam D. Levy - $17K of ACRV open-market activity in the last 12 months
- Mary Miller - $1K of ACRV open-market activity in the last 12 months
- Erick Gamelin - $804 of ACRV open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Charles M. Baum?
Charles M. Baum is a corporate insider of Acrivon Therapeutics, Inc. (ACRV). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Charles M. Baum submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Charles M. Baum's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Charles M. Baum and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
